Phenotyping of Heart Failure in CKD Using Electrocardiography Features
Kidney360 · 2026-07 · 7 (7) · 1588-1600
DOI: 10.34067/kid.0000001175 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kidney360, online erschienen am 24.03.2026. Verfasst von Qandeel H Soomro und 6 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology Division, New York University Grossman School of Medicine, New York, New York. Hauptthemen laut MEDLINE: Heart Failure, Electrocardiography, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, ASN Foundation for Kidney Research, Division of Diabetes, Endocrinology, and Metabolic Diseases, Division of Diabetes, Endocrinology, and Metabolic Diseases.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Key Points Electrocardiography features have incremental value in prediction of heart failure in CKD beyond clinical features. Comparison and integration in existing risk scores is needed.
Background
Tools for predicting heart failure in patients with CKD remain limited. We aimed to study whether standard electrocardiography (ECG) features or heart rate variability parameters predict de novo heart failure hospitalization in individuals with CKD.
Methods
Using a large New York University ECG database linked with electronic health records (2012–2021), we analyzed a cohort of patients with preexisting CKD. Besides standard ECG features, we extracted heart rate variability (measures the time between consecutive heart beats in milliseconds) features from the ECGs as predictors. The index ECG was the first ECG performed after the index eGFR date (baseline) and was required to be performed before initiation of dialysis, ESKD, or transplant. The primary outcome was time to index heart failure hospitalization (≥30 days after the index ECG) on the basis of discharge International Classification of Diseases, Tenth Revision codes. Least absolute shrinkage and selection operator–penalized Cox regression was used to identify predictors. Sensitivity analyses used Fine–Gray competing risk models for death and ESKD.
Results
Among 11,409 individuals (median age: 72 years; approximately 50% men) with a median of 976 days, 880 individuals (8%) experienced an index heart failure hospitalization. Models incorporating ECG and clinical parameters had excellent discrimination ( C -statistic 0.76 in the training set and 0.73 in the validation set). Among ECG features, the PR interval, corrected QT, and T axis were independently associated with higher risks of index heart failure hospitalization ≥30 days after the index ECG in both primary models ( P < 0.001 for all), and in models accounting for competing risks ( P < 0.01 for all). History of arrhythmia (hazard ratio [HR], 1.60; 95% confidence interval [CI], 1.36 to 1.88), valvular disease (HR, 1.51; 95% CI, 1.27 to 1.81), and diabetes (HR, 1.41; 95% CI, 1.22 to 1.65) were the strongest clinical predictors. Heart rate variability parameters were not independently associated with heart failure.
Conclusions
Although ECG-derived heart rate variability indices were not independently associated with risk of heart failure, several standard ECG features are associated with heart failure hospitalization in patients with CKD. Podcast This article contains a podcast at https://dts.podtrac.com/redirect.mp3/www.asn-online.org/media/podcast/K360/2026_07_30_KID0000001175.mp3
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Nephrology Division, New York University Grossman School of Medicine, New York, New York.
- Biostatistics Unit, Office of Academic Affairs, Northwell Health, New York, New York.
- Department of Surgery, NYU Grossman Long Island School of Medicine, New York, New York.
- Department of Foundations of Medicine, Center for Population and Health Services Research, NYU Grossman Long Island School of Medicine, New York, New York.
ORCID-Profile: Qandeel H Soomro, Niveda Shekar, Chinyere Okpara, Soo Young Kim, Jasmin Divers, David M Charytan
Förderung
- NIDDK NIH HHS
- ASN Foundation for Kidney Research, Division of Diabetes, Endocrinology, and Metabolic Diseases
- Division of Diabetes, Endocrinology, and Metabolic Diseases
Zitieren
APA
Soomro, Q. H., Shekar, N., Islam, S., Okpara, C., Kim, S. Y., Divers, J., & Charytan, D. M. (2026). Phenotyping of Heart Failure in CKD Using Electrocardiography Features. Kidney360, 7(7), 1588-1600. https://doi.org/10.34067/kid.0000001175
Vancouver
Soomro QH, Shekar N, Islam S, Okpara C, Kim SY, Divers J, et al. Phenotyping of Heart Failure in CKD Using Electrocardiography Features. Kidney360. 2026;7(7):1588-1600. doi:10.34067/kid.0000001175
BibTeX
@article{Soomro2026,
author = {Soomro, Qandeel H and Shekar, Niveda and Islam, Shahidul and Okpara, Chinyere and Kim, Soo Young and Divers, Jasmin and Charytan, David M},
title = {Phenotyping of Heart Failure in CKD Using Electrocardiography Features},
journal = {Kidney360},
year = {2026},
volume = {7},
number = {7},
pages = {1588--1600},
doi = {10.34067/kid.0000001175}
}
EUVIMED